nach oben

Seminars in Immunopathology

Erschienen in:

04.06.2018 | Review

Innate lymphoid cells—key immune integrators of overall body homeostasis

verfasst von: Fotios Karagiannis, Christoph Wilhelm

Erschienen in: Seminars in Immunopathology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

The maintenance of the tissue barrier is essential to protect the host from external pathogens, thus ensuring the survival of the organism. This process requires the integration of various physiological signals originating from the digestive, immune, endocrine, and the nervous system as indicators of overall body fitness. Innate lymphoid cells (ILC) are a group of immune cells equipped for the guarding and maintenance of the tissue barrier against invading pathogens. Extensive research has focused on the regulation of ILC by cytokines derived from immune or non-immune cells, such as the epithelium. However, recent findings suggest that ILC may play an additional role in the monitoring of the overall health status of the host. This requires the combined sensing of cytokines, metabolites, hormones, and neuropeptides. ILC appear to be essential in this process functioning as hubs for the integration of different physiological signals to facilitate barrier immunity. Here, we discuss the emerging literature revealing dietary, metabolic, hormonal, and neuronal signals as important controllers and modulators of ILC function in health and disease.

Sonnenberg GF, Artis D (2015) Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat Med 21:698–708. https://doi.org/10.1038/nm.3892 CrossRefPubMedPubMedCentral

Eberl G, Colonna M, Di Santo JP, McKenzie ANJ (2015) Innate lymphoid cells: a new paradigm in immunology. Science (80-) 348:aaa6566. https://doi.org/10.1126/science.aaa6566 CrossRef

Liu M, Zhang C (2017) The role of innate lymphoid cells in immune-mediated liver diseases. Front Immunol 8:695. https://doi.org/10.3389/fimmu.2017.00695 CrossRefPubMedPubMedCentral

Xiong T, Turner J (2018) Innate lymphoid cells in autoimmunity and chronic inflammatory diseases. Semin Immunopathol. https://doi.org/10.1007/s00281-018-0670-4

Spits H, Artis D, Colonna M, Diefenbach A, di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie ANJ, Mebius RE, Powrie F, Vivier E (2013) Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 13:145–149. https://doi.org/10.1038/nri3365 CrossRefPubMed

Constantinides MG, McDonald BD, Verhoef PA, Bendelac A (2014) A committed precursor to innate lymphoid cells. Nature 508:397–401. https://doi.org/10.1038/nature13047 CrossRefPubMedPubMedCentral

Klose CSN, Flach M, Möhle L, Rogell L, Hoyler T, Ebert K, Fabiunke C, Pfeifer D, Sexl V, Fonseca-Pereira D, Domingues RG, Veiga-Fernandes H, Arnold SJ, Busslinger M, Dunay IR, Tanriver Y, Diefenbach A (2014) Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157:340–356. https://doi.org/10.1016/j.cell.2014.03.030 CrossRefPubMed

Serafini N, Vosshenrich CAJ, Di Santo JP (2015) Transcriptional regulation of innate lymphoid cell fate. Nat Rev Immunol 15:415–428. https://doi.org/10.1038/nri3855 CrossRefPubMed

Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD, Cella M, Colonna M (2013) Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 38(4):769–781. https://doi.org/10.1016/j.immuni.2013.02.010 CrossRefPubMedPubMedCentral

10.

Bernink JH, Peters CP, Munneke M, te Velde AA, Meijer SL, Weijer K, Hreggvidsdottir HS, Heinsbroek SE, Legrand N, Buskens CJ, Bemelman WA, Mjösberg JM, Spits H (2013) Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 14:221–229. https://doi.org/10.1038/ni2534 CrossRefPubMed

11.

Zook EC, Kee BL (2016) Development of innate lymphoid cells. Nat Immunol 17:775–782. https://doi.org/10.1038/ni.3481 CrossRefPubMed

12.

Artis D, Spits H (2015) The biology of innate lymphoid cells. Nature 517:293–301CrossRefPubMed

13.

Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa JI, Ohtani M, Fujii H, Koyasu S (2010) Innate production of TH2 cytokines by adipose tissue-associated c-kit+Sca-1+ lymphoid cells. Nature 463:540–544. https://doi.org/10.1038/nature08636 CrossRefPubMed

14.

Price AE, Liang H-E, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, Locksley RM (2010) Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci 107:11489–11494. https://doi.org/10.1073/pnas.1003988107 CrossRefPubMed

15.

Mjösberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H (2011) Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12:1055–1062. https://doi.org/10.1038/ni.2104 CrossRefPubMed

16.

Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CGK, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T, Kubota M, Turner D, Diamond JM, Goldrath AW, Farber DL, Collman RG, Wherry EJ, Artis D (2011) Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12:1045–1054. https://doi.org/10.1038/ni.2131 CrossRefPubMedPubMedCentral

17.

Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JKM, Doherty JM, Mills JC, Colonna M (2009) A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457:722–725. https://doi.org/10.1038/nature07537 CrossRefPubMed

18.

Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F (2010) Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464:1371–1375. https://doi.org/10.1038/nature08949 CrossRefPubMedPubMedCentral

19.

Eder W, Ege MJ, von Mutius E (2006) The asthma epidemic. N Engl J Med 355:2226–2235. https://doi.org/10.1056/NEJMra054308 CrossRefPubMed

20.

Maslowski KM, MacKay CR (2011) Diet, gut microbiota and immune responses. Nat Immunol 12:5–9CrossRefPubMed

21.

Strachan DP (1989) Hay fever, hygiene, and household size. BMJ 299:1259–1260. https://doi.org/10.1136/bmj.299.6710.1259 CrossRefPubMedPubMedCentral

22.

Strachan DP (2000) Family size, infection and atopy: the first decade of the “hygiene hypothesis”. Thorax 55(Suppl 1):S2–S10. https://doi.org/10.1136/thorax.55.suppl_1.S2 CrossRefPubMedPubMedCentral

23.

Wills-Karp M, Santeliz J, Karp CL (2001) The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 1:69–75. https://doi.org/10.1038/35095579 CrossRefPubMed

24.

Yazdanbakhsh M, Kremsner PG, Van Ree R (2002) Immunology: allergy, parasites, and the hygiene hypothesis. Science (80-.) 296:490–494CrossRef

25.

Veldhoen M, Brucklacher-Waldert V (2012) Dietary influences on intestinal immunity. Nat Rev Immunol 12:696–708CrossRefPubMed

26.

Wheeler MA, Rothhammer V, Quintana FJ (2017) Control of immune-mediated pathology via the aryl hydrocarbon receptor. J Biol Chem 292:12383–12389CrossRefPubMedPubMedCentral

27.

Gu Y-Z, Hogenesch JB, Bradfield CA (2000) The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 40:519–561. https://doi.org/10.1146/annurev.pharmtox.40.1.519 CrossRefPubMed

28.

Cella M, Colonna M (2015) Aryl hydrocarbon receptor: linking environment to immunity. Semin Immunol 27:310–314CrossRefPubMedPubMedCentral

29.

Bernink JH, Krabbendam L, Germar K, de Jong E, Gronke K, Kofoed-Nielsen M, Munneke JM, Hazenberg MD, Villaudy J, Buskens CJ, Bemelman WA, Diefenbach A, Blom B, Spits H (2015) Interleukin-12 and -23 control plasticity of Cd127+ group 1 and group 3 innate lymphoid cells in the intestinal Lamina Propria. Immunity 43:146–160. https://doi.org/10.1016/j.immuni.2015.06.019 CrossRefPubMed

30.

Kiss EA, Vonarbourg C, Kopfmann S et al (2011) Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science (80-) 334:1561–1565. https://doi.org/10.1126/science.1214914 CrossRef

31.

Qiu J, Heller JJ, Guo X, Chen ZME, Fish K, Fu YX, Zhou L (2012) The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36:92–104. https://doi.org/10.1016/j.immuni.2011.11.011 CrossRefPubMed

32.

Li Y, Innocentin S, Withers DR, Roberts NA, Gallagher AR, Grigorieva EF, Wilhelm C, Veldhoen M (2011) Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147:629–640. https://doi.org/10.1016/j.cell.2011.09.025 CrossRefPubMed

33.

Lee JS, Cella M, McDonald KG et al (2012) AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of notch. Nat Immunol 13:144–152. https://doi.org/10.1038/ni.2187 CrossRef

34.

Schiering C, Wincent E, Metidji A, Iseppon A, Li Y, Potocnik AJ, Omenetti S, Henderson CJ, Wolf CR, Nebert DW, Stockinger B (2017) Feedback control of AHR signalling regulates intestinal immunity. Nature 542:242–245. https://doi.org/10.1038/nature21080 CrossRefPubMedPubMedCentral

35.

Zelante T, Iannitti RG, Cunha C, de Luca A, Giovannini G, Pieraccini G, Zecchi R, D’Angelo C, Massi-Benedetti C, Fallarino F, Carvalho A, Puccetti P, Romani L (2013) Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39:372–385. https://doi.org/10.1016/j.immuni.2013.08.003 CrossRefPubMed

36.

Hall JA, Grainger JR, Spencer SP, Belkaid Y (2011) The role of retinoic acid in tolerance and immunity. Immunity 35:13–22CrossRefPubMedPubMedCentral

37.

Duester G (2008) Retinoic acid synthesis and signaling during early organogenesis. Cell 134:921–931CrossRefPubMedPubMedCentral

38.

Liu Z-M, Wang K-P, Ma J, Guo Zheng S (2015) The role of all-trans retinoic acid in the biology of Foxp3+ regulatory T cells. Cell Mol Immunol 12:553–557. https://doi.org/10.1038/cmi.2014.133 CrossRefPubMedPubMedCentral

39.

Spencer SP, Wilhelm C, Yang Q et al (2014) Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science (80-) 343:432–437. https://doi.org/10.1126/science.1247606 CrossRef

40.

Mielke LA, Jones SA, Raverdeau M, Higgs R, Stefanska A, Groom JR, Misiak A, Dungan LS, Sutton CE, Streubel G, Bracken AP, Mills KHG (2013) Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation. J Exp Med 210:1117–1124. https://doi.org/10.1084/jem.20121588 CrossRefPubMedPubMedCentral

41.

Van De Pavert SA, Ferreira M, Domingues RG et al (2014) Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature 508:123–127. https://doi.org/10.1038/nature13158 CrossRefPubMedPubMedCentral

42.

Kim MH, Taparowsky EJ, Kim Correspondence CH, Kim CH (2015) Retinoic acid differentially regulates the migration of innate lymphoid cell subsets to the gut. Immunity 43:107–119. https://doi.org/10.1016/j.immuni.2015.06.009 CrossRefPubMedPubMedCentral

43.

Murakami M (2011) Lipid mediators in life science. Exp Anim 60:7–20. https://doi.org/10.1538/expanim.60.7 CrossRefPubMed

44.

de Jong AJ, Kloppenburg M, Toes RE, Ioan-Facsinay A (2014) Fatty acids, lipid mediators, and T-cell function. Front Immunol 5:483. https://doi.org/10.3389/fimmu.2014.00483 PubMedPubMedCentralCrossRef

45.

Theron AJ, Steel HC, Tintinger GR, Gravett CM, Anderson R, Feldman C (2014) Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function. J Immunol Res 2014:1–16

46.

Cavagnero K, Doherty TA (2017) Cytokine and lipid mediator regulation of group 2 innate lymphoid cells (ILC2s) in human allergic airway disease. J Cytokine Biol 2(2):116. https://doi.org/10.4172/2576-3881.1000116 CrossRefPubMedPubMedCentral

47.

Doherty TA, Khorram N, Lund S, Mehta AK, Croft M, Broide DH (2013) Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. J Allergy Clin Immunol 132:205–213. https://doi.org/10.1016/j.jaci.2013.03.048 CrossRefPubMedPubMedCentral

48.

von Moltke J, O’Leary CE, Barrett NA, Kanaoka Y, Austen KF, Locksley RM (2017) Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s. J Exp Med 214:27–37. https://doi.org/10.1084/jem.20161274 CrossRef

49.

Lund SJ, Portillo A, Cavagnero K, Baum RE, Naji LH, Badrani JH, Mehta A, Croft M, Broide DH, Doherty TA (2017) Leukotriene C4 potentiates IL-33-induced group 2 innate lymphoid cell activation and lung inflammation. J Immunol 199:1096–1104. https://doi.org/10.4049/jimmunol.1601569 CrossRefPubMedPubMedCentral

50.

Salimi M, Stöger L, Liu W, Go S, Pavord I, Klenerman P, Ogg G, Xue L (2017) Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines. J Allergy Clin Immunol 12:556–562. https://doi.org/10.1016/j.jaci.2016.12.958 CrossRef

51.

Ricciotti E, Fitzgerald GA (2011) Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 31:986–1000. https://doi.org/10.1161/ATVBAHA.110.207449 CrossRefPubMedPubMedCentral

52.

Boyce JA (2007) Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol Rev 217:168–185CrossRefPubMed

53.

Konya V, Mjösberg J (2016) Lipid mediators as regulators of human ILC2 function in allergic diseases. Immunol Lett 179:36–42. https://doi.org/10.1016/j.imlet.2016.07.006 CrossRefPubMed

54.

Xue L, Salimi M, Panse I, Mjösberg JM, McKenzie ANJ, Spits H, Klenerman P, Ogg G (2014) Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol 133:1184–1194.e7. https://doi.org/10.1016/j.jaci.2013.10.056 CrossRefPubMedPubMedCentral

55.

Barnig C, Cernadas M, Dutile S, Liu X, Perrella MA, Kazani S, Wechsler ME, Israel E, Levy BD (2013) Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med 5:174ra26. https://doi.org/10.1126/scitranslmed.3004812 CrossRefPubMed

56.

Tait Wojno ED, Monticelli LA, Tran SV, Alenghat T, Osborne LC, Thome JJ, Willis C, Budelsky A, Farber DL, Artis D (2015) The prostaglandin D2 receptor CRTH2 regulates accumulation of group 2 innate lymphoid cells in the inflamed lung. Mucosal Immunol 8:1313–1323. https://doi.org/10.1038/mi.2015.21 CrossRefPubMedCentral

57.

Dorris SL, Peebles RS (2012) PGI2 as a regulator of inflammatory diseases. Mediat Inflamm 2012:926968. https://doi.org/10.1155/2012/926968 CrossRef

58.

Zhou W, Toki S, Zhang J, Goleniewksa K, Newcomb DC, Cephus JY, Dulek DE, Bloodworth MH, Stier MT, Polosuhkin V, Gangula RD, Mallal SA, Broide DH, Peebles RS Jr (2016) Prostaglandin I2 signaling and inhibition of group 2 innate lymphoid cell responses. Am J Respir Crit Care Med 193:31–42. https://doi.org/10.1164/rccm.201410-1793OC CrossRefPubMedPubMedCentral

59.

Harizi H (2013) The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunity. Biomed Res Int 2013:683405. https://doi.org/10.1155/2013/683405 CrossRefPubMedPubMedCentral

60.

Smith CL, Dickinson P, Forster T, Craigon M, Ross A, Khondoker MR, France R, Ivens A, Lynn DJ, Orme J, Jackson A, Lacaze P, Flanagan KL, Stenson BJ, Ghazal P (2014) Identification of a human neonatal immune-metabolic network associated with bacterial infection. Nat Commun 5. https://doi.org/10.1038/ncomms5649

61.

Duffin R, OConnor RA, Crittenden S et al (2016) Prostaglandin E2 constrains systemic inflammation through an innate lymphoid cell-IL-22 axis. Science (80-) 351:1333–1338. https://doi.org/10.1126/science.aad9903 CrossRef

62.

Maric J, Ravindran A, Mazzurana L, Björklund ÅK, van Acker A, Rao A, Friberg D, Dahlén SE, Heinemann A, Konya V, Mjösberg J (2017) PGE 2 suppresses human group 2 innate lymphoid cell function. J Allergy Clin Immunol. https://doi.org/10.1016/j.jaci.2017.09.050

63.

Serhan CN (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and Proresolving lipid mediators and pathways. Annu Rev Immunol 25:101–137. https://doi.org/10.1146/annurev.immunol.25.022106.141647 CrossRefPubMed

64.

Takabe K, Paugh SW, Milstien S, Spiegel S (2008) “Inside-out” signaling of Sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 60:181–195. https://doi.org/10.1124/pr.107.07113 CrossRefPubMedPubMedCentral

65.

Huang Y, Mao K, Chen X, Sun MA, Kawabe T, Li W, Usher N, Zhu J, Urban JF Jr, Paul WE, Germain RN (2018) S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense. Science 359:114–119. https://doi.org/10.1126/science.aam5809 CrossRefPubMed

66.

Talbot S, Foster SL, Woolf CJ (2016) Neuroimmunity: physiology and pathology. Annu Rev Immunol 34:421–447. https://doi.org/10.1146/annurev-immunol-041015-055340 CrossRefPubMed

67.

Chiu IM, Von Hehn CA, Woolf CJ (2012) Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat Neurosci 15:1063–1067CrossRefPubMedPubMedCentral

68.

Foster SL, Seehus CR, Woolf CJ, Talbot S (2017) Sense and immunity: context-dependent neuro-immune interplay. Front Immunol 8:1463. https://doi.org/10.3389/fimmu.2017.01463 CrossRefPubMedPubMedCentral

69.

Klose CSN, Mahlakõiv T, Moeller JB, Rankin LC, Flamar AL, Kabata H, Monticelli LA, Moriyama S, Putzel GG, Rakhilin N, Shen X, Kostenis E, König GM, Senda T, Carpenter D, Farber DL, Artis D (2017) The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation. Nature 549:282–286. https://doi.org/10.1038/nature23676 CrossRefPubMedPubMedCentral

70.

Wallrapp A, Riesenfeld SJ, Burkett PR, Abdulnour REE, Nyman J, Dionne D, Hofree M, Cuoco MS, Rodman C, Farouq D, Haas BJ, Tickle TL, Trombetta JJ, Baral P, Klose CSN, Mahlakõiv T, Artis D, Rozenblatt-Rosen O, Chiu IM, Levy BD, Kowalczyk MS, Regev A, Kuchroo VK (2017) The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. Nature 549:351–356. https://doi.org/10.1038/nature24029 CrossRefPubMedPubMedCentral

71.

Cardoso V, Chesné J, Ribeiro H, García-Cassani B, Carvalho T, Bouchery T, Shah K, Barbosa-Morais NL, Harris N, Veiga-Fernandes H (2017) Neuronal regulation of type 2 innate lymphoid cells via neuromedin U. Nature 549:277–281. https://doi.org/10.1038/nature23469 CrossRefPubMedPubMedCentral

72.

Ganea D, Hooper KM, Kong W (2015) The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases. Acta Physiol (Oxf) 213:442–452. https://doi.org/10.1111/apha.12427 CrossRef

73.

Talbot S, Abdulnour REE, Burkett PR, Lee S, Cronin SJF, Pascal MA, Laedermann C, Foster SL, Tran JV, Lai N, Chiu IM, Ghasemlou N, DiBiase M, Roberson D, von Hehn C, Agac B, Haworth O, Seki H, Penninger JM, Kuchroo VK, Bean BP, Levy BD, Woolf CJ (2015) Silencing nociceptor neurons reduces allergic airway inflammation. Neuron 87:341–355. https://doi.org/10.1016/j.neuron.2015.06.007 CrossRefPubMedPubMedCentral

74.

Nussbaum JC, Van Dyken SJ, Von Moltke J et al (2013) Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502:245–248. https://doi.org/10.1038/nature12526 CrossRefPubMedPubMedCentral

75.

Moriyama S, Brestoff JR, Flamar A-L et al (2018) β2 −adrenergic receptor–mediated negative regulation of group 2 innate lymphoid cell responses. Science (80-) 359:1056–1061. https://doi.org/10.1126/science.aan4829 CrossRef

76.

Ibiza S, García-Cassani B, Ribeiro H, Carvalho T, Almeida L, Marques R, Misic AM, Bartow-McKenney C, Larson DM, Pavan WJ, Eberl G, Grice EA, Veiga-Fernandes H (2016) Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Nature 535:440–443. https://doi.org/10.1038/nature18644 CrossRefPubMedPubMedCentral

77.

Ashwell JD, Lu FW, Vacchio MS (2000) Glucocorticoids in T cell development and function. Annu Rev Immunol 18:309–345. https://doi.org/10.1146/annurev.immunol.18.1.309 CrossRefPubMed

78.

Cain DW, Cidlowski JA (2017) Immune regulation by glucocorticoids. Nat Rev Immunol 17:233–247CrossRefPubMed

79.

Miller WL, Auchus RJ (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 32:81–151. https://doi.org/10.1210/er.2010-0013 CrossRefPubMed

80.

Dunn AJ (2000) Cytokine activation of the HPA Axis. Ann N Y Acad Sci 917:608–617. https://doi.org/10.1111/j.1749-6632.2000.tb05426.x CrossRefPubMed

81.

Quatrini L, Wieduwild E, Guia S, Bernat C, Glaichenhaus N, Vivier E, Ugolini S (2017) Host resistance to endotoxic shock requires the neuroendocrine regulation of group 1 innate lymphoid cells. J Exp Med 214(12):3531–3541. https://doi.org/10.1084/jem.20171048 CrossRefPubMedPubMedCentral

82.

Kabata H, Moro K, Fukunaga K, Suzuki Y, Miyata J, Masaki K, Betsuyaku T, Koyasu S, Asano K (2013) Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation. Nat Commun 4:2675. https://doi.org/10.1038/ncomms3675 CrossRefPubMed

83.

Laffont S, Blanquart E, Guery JC (2017) Sex differences in asthma: a key role of androgen-signaling in group 2 innate lymphoid cells. J Immunol 8:1069. https://doi.org/10.3389/fimmu.2017.01069 CrossRef

84.

Laffont S, Blanquart E, Savignac M, Cénac C, Laverny G, Metzger D, Girard JP, Belz GT, Pelletier L, Seillet C, Guéry JC (2017) Androgen signaling negatively controls group 2 innate lymphoid cells. J Exp Med 214:1581–1592. https://doi.org/10.1084/jem.20161807 CrossRefPubMedPubMedCentral

85.

Cephus JY, Stier MT, Fuseini H, Yung JA, Toki S, Bloodworth MH, Zhou W, Goleniewska K, Zhang J, Garon SL, Hamilton RG, Poloshukin VV, Boyd KL, Peebles RS Jr, Newcomb DC (2017) Testosterone attenuates group 2 innate lymphoid cell-mediated airway inflammation. Cell Rep 21:2487–2499. https://doi.org/10.1016/j.celrep.2017.10.110 CrossRefPubMedPubMedCentral

86.

Bartemes K, Chen CC, Iijima K, Drake L, Kita H (2018) IL-33-responsive group 2 innate lymphoid cells are regulated by female sex hormones in the uterus. J Immunol 200(1):229–236. https://doi.org/10.4049/jimmunol.1602085 CrossRefPubMed

Titel: Innate lymphoid cells—key immune integrators of overall body homeostasis
verfasst von: Fotios Karagiannis
Christoph Wilhelm
Publikationsdatum: 04.06.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Seminars in Immunopathology / Ausgabe 4/2018
Print ISSN: 1863-2297
Elektronische ISSN: 1863-2300
DOI: https://doi.org/10.1007/s00281-018-0684-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Innate lymphoid cells—key immune integrators of overall body homeostasis

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Innate lymphoid cells in autoimmunity and chronic inflammatory diseases

Orchestration of intestinal homeostasis and tolerance by group 3 innate lymphoid cells

Memory responses of innate lymphocytes and parallels with T cells

AHR signaling in the development and function of intestinal immune cells and beyond

ILC2s in infectious diseases and organ-specific fibrosis

The roles for innate lymphoid cells in the human immune system

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin